Clinical trial
Safety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary…
NCT00251823 · Ottawa Heart Institute Research Corporation, Other · Completed
Key facts
| NCT number | NCT00251823 |
|---|---|
| Title | Safety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary Intervention (PCI) |
| Official title | The Safety and Efficacy of Eptifibatide-Facilitated Percutaneous Coronary Angioplasty Versus Primary Percutaneous Coronary Angioplasty Alone |
| Lead sponsor | Ottawa Heart Institute Research Corporation, Other |
| Collaborators | Schering-Plough Industry Medtronic |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Eptifibatide facilitated PCI |
| Enrollment | 400 |
| Start date | Jul 1, 2005 |
| Completion | Sep 1, 2008 |
| First posted | Nov 10, 2005 |
| Last update posted | Sep 4, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: